Calidi Biotherapeutics Inc (CLDI)

$5.94 -0.24 (-3.88%)
Market Cap 21.94M
Revenue (ttm) 0.00
Net Income (ttm) -22.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.08
Volume 174,102
Avg Vol 1,795,005
Day's Range N/A - N/A
Shares Out 3.03M
Stochastic %K 33%
Beta 1.15
Analysts Strong Sell
Price Target $120.05

Company Profile

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcino...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 794 9600
Fax: 858 794 9605
Address:
4475 Executive Drive, Suite 200, San Diego, United States
Luke904
Luke904 Aug. 7 at 6:51 PM
$CLDI what’s our predictions with this?
0 · Reply
uindicator
uindicator Aug. 7 at 2:09 PM
$CLDI starting to think this is all fugazi, no partners interested
0 · Reply
race2zero
race2zero Aug. 7 at 1:36 PM
$CLDI so easy, and wait until the dilution starts..
0 · Reply
race2zero
race2zero Aug. 7 at 1:32 PM
$CLDI doesn’t matter the float, people see this as a sub $1 stock….will continue to bleed its way down there
0 · Reply
Crcarlson8456
Crcarlson8456 Aug. 7 at 1:56 AM
$CLDI
0 · Reply
Crcarlson8456
Crcarlson8456 Aug. 6 at 11:30 PM
$CLDI break of 6.00 and the shorts will push this down. so long as there are no buyers we will be heading there. the chart movement to me looks manipulated. would appreciate if somone could help me understand the no volume drops after market close. Reminds me of the slow drop down to .20 a few months back… is this dark pool volume that we just cant see? i cant make any sense of the charts…
1 · Reply
Yourmom864
Yourmom864 Aug. 6 at 9:07 PM
$CLDI 🤔 anybody else taken back by the fact that obvious frauds like this sink slowly, but others ride by and fall by a ton all the time?
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 6 at 7:17 PM
New Genetic Discovery Could Boost Cancer Immunotherapy $CLDI #TinyGems #Cancer https://ibn.fm/YruKF
0 · Reply
uindicator
uindicator Aug. 6 at 6:31 PM
$CLDI until they actually show any kind of progress with their trials, this is going to bleed down
2 · Reply
Crcarlson8456
Crcarlson8456 Aug. 6 at 5:18 PM
$CLDI bouncing around the range we have been in all week. Anyones guess as to what happens next. good luck!
0 · Reply
Latest News on CLDI
Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Jul 25, 2025, 4:45 PM EDT - 12 days ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Jul 22, 2025, 8:00 AM EDT - 16 days ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Jul 10, 2025, 8:30 AM EDT - 4 weeks ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Jul 9, 2025, 2:01 PM EDT - 4 weeks ago

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Jul 8, 2025, 8:30 AM EDT - 4 weeks ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Jun 27, 2025, 8:00 AM EDT - 5 weeks ago

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Apr 25, 2025, 8:00 AM EDT - 3 months ago

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

Apr 16, 2025, 9:30 AM EDT - 4 months ago

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 31, 2025, 4:30 PM EDT - 4 months ago

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 28, 2025, 9:00 AM EDT - 4 months ago

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Mar 10, 2025, 8:00 AM EDT - 5 months ago

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Feb 28, 2025, 9:00 AM EST - 5 months ago

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

OSTX

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Feb 24, 2025, 8:00 AM EST - 5 months ago

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Jan 29, 2025, 8:00 AM EST - 6 months ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Jan 28, 2025, 8:00 AM EST - 6 months ago

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 4:30 PM EST - 7 months ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 8:30 AM EST - 7 months ago

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Proposed Public Offering

Jan 8, 2025, 4:01 PM EST - 7 months ago

Calidi Biotherapeutics Announces Proposed Public Offering

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Nov 15, 2024, 4:05 PM EST - 9 months ago

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Nov 14, 2024, 8:30 AM EST - 9 months ago

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Nov 12, 2024, 5:29 PM EST - 9 months ago

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Oct 25, 2024, 9:00 AM EDT - 10 months ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

NXL

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Oct 24, 2024, 8:30 AM EDT - 10 months ago

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Oct 23, 2024, 8:31 AM EDT - 10 months ago

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Oct 18, 2024, 11:00 PM EDT - 10 months ago

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Oct 18, 2024, 8:45 AM EDT - 10 months ago

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GRRR

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

Aug 13, 2024, 5:37 PM EDT - 1 year ago

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Aug 2, 2024, 9:00 AM EDT - 1 year ago

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GP

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

Jul 29, 2024, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

Jul 18, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

Jul 16, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

Calidi to Effect Reverse Stock Split

Jul 5, 2024, 4:15 PM EDT - 1 year ago

Calidi to Effect Reverse Stock Split

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Jun 27, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Jun 11, 2024, 4:05 PM EDT - 1 year ago

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

Jun 10, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting

Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

May 31, 2024, 8:51 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

May 17, 2024, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

UMAC

Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results

May 14, 2024, 4:05 PM EDT - 1 year ago

Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

May 1, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24

Apr 23, 2024, 7:00 AM EDT - 1 year ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on April 24

Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering

Apr 19, 2024, 4:05 PM EDT - 1 year ago

Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering

Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering

Apr 16, 2024, 8:31 AM EDT - 1 year ago

Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering

Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024

Apr 9, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results

Mar 15, 2024, 4:05 PM EDT - 1 year ago

Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results

Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer

Mar 11, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer

Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference

Feb 12, 2024, 7:00 AM EST - 1 year ago

Calidi Biotherapeutics to Highlight Novel Systemic Enveloped Oncolytic Virotherapy Platform Designed to Target All Tumor Sites at Upcoming Conference

Luke904
Luke904 Aug. 7 at 6:51 PM
$CLDI what’s our predictions with this?
0 · Reply
uindicator
uindicator Aug. 7 at 2:09 PM
$CLDI starting to think this is all fugazi, no partners interested
0 · Reply
race2zero
race2zero Aug. 7 at 1:36 PM
$CLDI so easy, and wait until the dilution starts..
0 · Reply
race2zero
race2zero Aug. 7 at 1:32 PM
$CLDI doesn’t matter the float, people see this as a sub $1 stock….will continue to bleed its way down there
0 · Reply
Crcarlson8456
Crcarlson8456 Aug. 7 at 1:56 AM
$CLDI
0 · Reply
Crcarlson8456
Crcarlson8456 Aug. 6 at 11:30 PM
$CLDI break of 6.00 and the shorts will push this down. so long as there are no buyers we will be heading there. the chart movement to me looks manipulated. would appreciate if somone could help me understand the no volume drops after market close. Reminds me of the slow drop down to .20 a few months back… is this dark pool volume that we just cant see? i cant make any sense of the charts…
1 · Reply
Yourmom864
Yourmom864 Aug. 6 at 9:07 PM
$CLDI 🤔 anybody else taken back by the fact that obvious frauds like this sink slowly, but others ride by and fall by a ton all the time?
0 · Reply
NetworkNewsWire
NetworkNewsWire Aug. 6 at 7:17 PM
New Genetic Discovery Could Boost Cancer Immunotherapy $CLDI #TinyGems #Cancer https://ibn.fm/YruKF
0 · Reply
uindicator
uindicator Aug. 6 at 6:31 PM
$CLDI until they actually show any kind of progress with their trials, this is going to bleed down
2 · Reply
Crcarlson8456
Crcarlson8456 Aug. 6 at 5:18 PM
$CLDI bouncing around the range we have been in all week. Anyones guess as to what happens next. good luck!
0 · Reply
race2zero
race2zero Aug. 6 at 2:34 PM
$CLDI it’s about to get real ugly here….easy short
1 · Reply
_www_larval_com_
_www_larval_com_ Aug. 6 at 2:17 PM
$CLDI has dropped -10% lower to -13% (~55Kv) a moment ago, follow for more volatility.
0 · Reply
uindicator
uindicator Aug. 6 at 2:06 PM
$CLDI the new CEO has the personality of a chalkboard, no excitement whatsoever coming from this guy, makes this company look boorrring
0 · Reply
bullfirst
bullfirst Aug. 6 at 2:04 PM
$CLDI time to delist!
0 · Reply
race2zero
race2zero Aug. 6 at 2:04 PM
$CLDI give it time…
0 · Reply
Stockttwits619
Stockttwits619 Aug. 6 at 9:20 AM
$CLDI We got Lucky on this one, usually 50-75% loss after RS
2 · Reply
Gest1010
Gest1010 Aug. 6 at 12:54 AM
$CLDI After stock reverse split my 8 stocks disappeared, then money was gone. WTF!!!
1 · Reply
TwongStocks
TwongStocks Aug. 5 at 8:05 PM
Today's reverse split results. 2 up, 2 down: $ACXP 1 for 20 Previous close $0.2924, $5.848 split-adjusted Today's close $5.09 🔴Down 12.96% $CLDI 1 for 12 Previous close $0.5931, $7.1172 split-adjusted Today's close $7.25 🟢Up 1.87% $MKZR 1 for 10 Previous close $0.509999, $5.09999 split-adjusted Today's close $4.92 🔴Down 3.53% $OST 1 for 25 Previous close $0.08, $2.00 split-adjusted Today's close $2.14 🟢Up 7.0%
1 · Reply
SC_penny
SC_penny Aug. 5 at 7:57 PM
$CLDI i have to admit this the recovery from this morning drop just convinced me that something great is on it way!
0 · Reply
MxPw
MxPw Aug. 5 at 5:53 PM
$CLDI random pop day to $28 then hardest sell off , when no idea , nor why. but im using some of the profits made off this to target that be it 6 months or 2 years , glta 🚀
0 · Reply
chanimalll
chanimalll Aug. 5 at 5:19 PM
$CLDI shameful, took a big loss before the RS
1 · Reply
Crcarlson8456
Crcarlson8456 Aug. 5 at 3:19 PM
$CLDI Dont forget. 0 shares available for shorting. none of the shorts sold this morning on the dip. Greedy bastards. let this play out here. still bullish short term.
0 · Reply